(Q46252490)

20 December 2017

title

Differential effects on T-cell function following exposure to serum from schizophrenia smokers (English)

1 reference

20 December 2017

0 references

9

S Bahn

1 reference

20 December 2017

M Herberth

1

1 reference

20 December 2017

D N Krzyszton

2

1 reference

20 December 2017

D Koethe

3

1 reference

20 December 2017

M R Craddock

4

1 reference

20 December 2017

E Bulger

5

1 reference

20 December 2017

E Schwarz

6

1 reference

20 December 2017

P Guest

7

1 reference

20 December 2017

F M Leweke

8

1 reference

20 December 2017

language of work or name

English

0 references

publication date

11 November 2008

1 reference

20 December 2017

published in

Molecular Psychiatry

1 reference

20 December 2017

volume

15

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

364-371

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/mp.2008.120

exact match

0 references

cites work

Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Co-morbidity of smoking in patients with psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine use in schizophrenia: the self medication hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine effects on brain function and functional connectivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine improves delayed recognition in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Schizophrenia and increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Chronic self-administration of nicotine in rats impairs T cell responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Decreased T cellular immune response in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Molecular analysis of CD26-mediated signal transduction in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Chart-recorded psychiatric diagnoses in women giving birth in California in 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Initial phase 2 trial of a nicotinic agonist in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Elimination of cotinine from body fluids: disposition in smokers and nonsmokers

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Factors affecting smoking in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.120

7 January 2021

Identifiers

DOI

10.1038/MP.2008.120

1 reference

20 December 2017

1 reference

20 December 2017